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Abstract 
A major goal for the revision of the International Classification of Diseases and Related Health 
Problems, Tenth Edition (ICD-10) is to increase the clinical utility of the diagnostic system. 
Schizoaffective Disorder has a history of poor diagnostic reliability due to the similarities and 
overlap in symptoms that it shares with other disorders, especially primary psychotic and mood 
disorders. The present study was part of the case-controlled field trials for ICD-11 and examines 
how the proposed changes for Schizoaffective Disorder may improve differential diagnosis and 
diagnostic accuracy. Clinicians from around the globe (n = 873) were provided with either ICD-
10 or ICD-11 diagnostic guidelines and asked to apply them to case vignettes comparing 
Schizoaffective Disorder to Schizophrenia and mood disorders with psychotic symptoms. 
Participants were asked to respond to follow-up diagnostic questions to determine which 
components of the diagnostic guidelines affected diagnostic accuracy. Overall, clinicians showed 
small improvements in accurately diagnosing vignettes using ICD-11 over ICD-10. Results 
suggest the discrepancy in diagnosing Schizoaffective Disorder is related primarily to the 
presence of mood symptoms and discrepancies about whether those symptoms are more 
consistent with Schizoaffective Disorder or a mood disorder diagnosis. Continuing to identify 
ways to more accurately capture this symptom picture will be important in the future as well as 
systematic efforts to educate clinicians about differential diagnosis.  
Keywords: ICD-11; Diagnosis; Schizoaffective Disorder; Schizophrenia; Mood Disorders; 
Reliability 
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1. Introduction 
The World Health Organization is nearing completion of the Eleventh Revision of the 
International Classification of Diseases and Related Health Problems (ICD-11), which is due to 
be approved by the World Health Assembly in 2019. A primary objective for changes to the 
ICD-11 classification of mental disorders as compared to ICD-10 has been to increase clinical 
utility (Reed, 2010). The World Health Organization (WHO) has defined clinical utility as the 
ability of diagnostic concepts to aid in communication and understanding about a diagnosis, their 
ability to be applied in clinical settings, and their ability to aid in prognostic knowledge and 
treatment planning (Reed, 2010). This definition includes traditional concepts of diagnostic 
reliability and accuracy, which are necessary for meeting other functions like communication. 
WHO aimed to give practitioners a tool that would better align with their practical needs related 
to diagnosing and treating mental disorders (First, 2010; Reed, 2010). It is important for 
clinicians to have an understanding of the diagnostic concepts they use and for that 
understanding to be applicable across world regions. 
The diagnostic guidelines for Schizoaffective Disorder are an area of particular interest in 
the present revision process (Gaebel, 2012). Schizoaffective Disorder has longstanding issues 
with validity and reliability, in addition to continued questions regarding how the diagnosis 
should be most accurately classified (Malaspina et al., 2013; Malhi et al., 2008). A meta-analysis 
of 49 publications revealed that the mean test-retest reliability of Schizoaffective Disorder (κ = 
.50, 95%CI .40-.59) was consistently lower than its differential diagnoses of Schizophrenia (κ = 
.69, 95%CI .64-.74), Bipolar Disorder (κ = .77, 95%CI .73-.82) and Unipolar Depression (κ = 
.73, 95%CI .66-.79; Santelmann et al., 2015). Schizoaffective Disorder is characterized by 
psychotic symptoms occurring concomitantly with mood symptoms of either polarity. This 
combination of symptoms can be challenging for clinicians when differentiating this diagnosis 
from diagnostic categories characterized mainly by psychotic symptoms (as seen with 
Schizophrenia and Other Primary Psychotic Disorders) or from mood disorders with psychotic 
symptoms. One factor that potentially contributes to this confusion is that psychotic disorders 
appear to exist upon a continuum of symptom severity as opposed to being discrete diagnostic 
entities, and Schizoaffective Disorder adds an additional dimension of the presence of mood 
symptoms (Jonathan et al., 2013; Kendell and Jablensky, 2003; Malhi et al., 2008). 
ICD-11 defines Schizoaffective Disorder as having all the features required for 
Schizophrenia in concurrence or within a few days of a mood episode. Psychotic and mood 
symptoms must be present for at least 4 weeks, and symptoms are not better accounted for by 
another condition (Gaebel et al., 2012). ICD-11 guidelines are different from the criteria in 
DSM-5, which conceptualize Schizoaffective Disorder as a longitudinal (principally life-long) 
disease course and not a cross-sectional observation at the time of clinical contact as in ICD-11. 
In addition, DSM-5 requires that hallucinations or delusions be present for at least two weeks 
without the presence of mood symptoms (APA, 2013). The WHO Working Group for 
Schizophrenia and Other Primary Psychotic Disorders considered the longitudinal approach 
problematic because in clinical practice it may be difficult for patients or clinicians to ascertain 
the presence of past psychotic or mood episodes and their temporal relationships with sufficient 
diagnostic accuracy. 
In contrast, ICD-10 defines Schizoaffective Disorder as the presence of at least one of the 
core symptoms (“a-d” in ICD-10) of Schizophrenia and two concurrent symptoms of a mood 
episode (WHO, 1992). A consequence of this structure was that the episode of illness did not 
meet diagnostic requirements for either Schizophrenia or a Depressive or Manic Episode. Thus, 
the presence of symptoms not sufficient to diagnose Schizophrenia or mood disorders could be 
diagnosed as Schizoaffective Disorder in ICD-10. On the other hand, the ICD-10 stated that if 
both schizophrenic and affective symptoms developed together and were evenly balanced, the 
diagnosis of Schizoaffective Disorder (F25.-) should be made, even if the schizophrenic 
symptoms by themselves would have justified the diagnosis of Schizophrenia (WHO, 1992). The 
ICD-11 sought to resolve such ambiguities and inconsistencies by requiring that all the 
requirements of Schizophrenia and at least a Depressive Episode of moderate severity or a Manic 
or Mixed Episode must be present. Subthreshold symptoms can be specified using the new ICD-
11 symptom qualifiers for primary psychotic disorders (Keeley & Gaebel, 2018), avoiding the 
need to classify the presence of subthreshold psychotic states in mood disorders or subthreshold 
mood states in psychotic disorders as Schizoaffective Disorder. In diagnoses of mood disorders 
with psychotic symptoms, the diagnosis can shift to Schizoaffective Disorder if psychotic 
symptoms reach the threshold for a diagnosis of Schizophrenia. 
The current study is part of a larger set of WHO studies investigating the clinical utility 
of various diagnostic areas (Keeley et al., 2016). This study focuses on Schizoaffective Disorder. 
Specifically, our research question was whether clinicians would be able to accurately diagnose 
Schizoaffective Disorder and differentiate it from other similar symptom profiles (i.e., 
Schizophrenia, Depressive Episode with Psychotic Symptoms, Manic Episode with Psychotic 
Symptoms) using case vignettes. Improved diagnostic accuracy (identifying the correct 
diagnosis) and reliability (coming to the same diagnostic conclusion) relative to ICD-10 would 
support the clinical utility of the ICD-11 guidelines.   
2. Method 
2.1 Participants 
 Participants were drawn from the Global Clinical Practice Network (GCPN; Reed et al., 
2015), a worldwide network of mental health and allied professionals established for the purpose 
of the ICD-11 case-controlled field trials. Professionals were invited to join the GCPN through 
professional listservs; national and regional professional associations; international and national 
conferences in psychology, psychiatry, and related disciplines; and professional word-of-mouth. 
The study was administered in six languages: Chinese, English, French, Japanese, Russian, and 
Spanish. At the time the study was launched, 9323 GCPN members were eligible for the study 
and were invited to participate. To qualify, the participant must have endorsed a self-rated 
proficiency of being either advanced or fluent in one of the six languages of the study, and was 
seeing patients or engaged in clinical supervision. If a participant endorsed fluency in multiple 
languages, the participant was assigned to participate in his or her primary professional language, 
if available. Of the eligible and valid participants, 2629 (28.2%) responded to the survey link and 
began the study. Of those who agreed to participate, most (n = 2330; 88.6%) completed the study 
(25.0% of the total invited).  
 The present study examined the portion of the overall sample that completed parts of the 
study relevant to the diagnosis of Schizoaffective Disorder. Thus, the final sample for the current 
analyses consisted of 873 mental health and allied professionals representing 81 different 
nationalities. The regional distribution of participants can be found in Table 1, along with their 
gender, profession, and mean age and years of experience.  
2.2 Materials 
 The survey was administered through Qualtrics, a web-based survey program. The 
materials in the survey included (a) diagnostic guidelines for ICD-11 and ICD-10 (psychotic 
disorders, depressive and manic episodes with psychotic features, and acute stress reaction), (b) a 
series of 10 vignettes for diagnostic comparisons (only 4 of which are presented here), and (c) a 
variety of diagnostic and clinical utility questions regarding the vignettes. Specifically, 
participants provided a diagnosis for a vignette and then answered questions about the presence 
or absence of each diagnostic guideline for the diagnosis they selected. The specific queries were 
adapted from the wording of ICD-10 or ICD-11 diagnostic guidelines. Results from the clinical 
utility questions are not included in this paper. For more information on study translation 
procedures, see Keeley et al. (2016). 
 Members of the WHO Working Group for Schizophrenia and Other Primary Psychotic 
Disorders developed the vignettes. Working Group members wrote vignettes based on actual 
patients (obscuring any personal details for confidentiality), which were then adapted by the 
corresponding author (JK) to meet the required experimental constraints (e.g., number and type 
of symptoms in the vignette). We explicitly developed the vignettes to reflect real cases to 
maximize applicability of the findings to clinical practice, given the artificial nature of vignette 
studies (Evans et al., 2015). Vignettes are available from the corresponding author upon request. 
 Each vignette was developed to meet all the diagnostic requirements for a specific 
disorder. To determine if the intended characteristics were indeed present, a group of content 
experts pretested vignettes to confirm the presence or absence of required features. Pretesting 
also confirmed expert consensus about the correct diagnosis for the case. Based on the results of 
the pretest, some vignettes were modified to clarify content or ensure that specific symptoms 
were recognizable. 
2.3 Procedure 
 Participants received an e-mail invitation to participate in the study through Qualtrics. 
Upon entry to the study, participants were randomly assigned to view and use either the ICD-10 
or ICD-11 diagnostic guidelines. Once participants had reviewed the guidelines, they were 
randomly assigned to one of eight comparisons (Comparisons 1-3 are the focus of this paper). 
Each comparison reflected a specific diagnostic distinction between similar disorders. Within 
each comparison, participants viewed two vignettes counterbalanced for presentation order. Once 
the participants had viewed a vignette, they were asked to provide a diagnosis from a preset list 
based on the diagnostic guidelines they were assigned. Participants were given the option of 
writing in another diagnosis if their selection was not present, or indicating that no diagnosis was 
warranted. Participants then rated the specific presence or absence of each diagnostic guideline 
for the diagnosis they gave. At that point, clinicians were given the option of selecting a different 
final diagnosis. Participants then rated the diagnostic and clinical utility questions. Participants 
then completed the sequence again for a second vignette. The description of the specific 
comparisons included in this study follows. 
 Comparison 1 – Schizophrenia (Vignette 1) vs. Schizoaffective Disorder (Vignette 2).  
The first comparison examined clinicians’ ability to differentiate Schizophrenia from 
Schizoaffective Disorder. More specifically, Vignette 1 had sufficient psychotic symptoms for a 
diagnosis of Schizophrenia but did not evidence any mood symptoms, whereas Vignette 2 
included sufficient symptoms for a diagnosis of a Depressive Episode that overlapped in time 
with symptoms of Schizophrenia.  
 Comparison 2 – Schizoaffective Disorder (Vignette 2) vs. Depressive Episode with 
Psychotic Symptoms (Vignette 3A).  The second comparison tested clinicians’ ability to 
differentiate Schizoaffective Disorder from a Depressive Episode with Psychotic Symptoms. The 
difference between the two cases was that psychotic symptoms for Vignette 3A did not meet the 
full requirements for Schizophrenia.  
 Comparison 3 – Schizoaffective Disorder (Vignette 2) vs. Manic Episode with Psychotic 
Symptoms (Vignette 3B).  Comparison 3 mirrored Comparison 2, but changed the mood episode 
in Vignette 3B from depressive to manic. Otherwise, the distinction remained the same. 
3. Results 
3.1 Diagnostic Agreement 
 Diagnostic agreement for Schizoaffective Disorder was calculated for both ICD-11 and 
ICD-10 diagnostic guidelines. Whereas Cohen’s kappa for ICD-11 Schizoaffective Disorder was 
.38 (.32-.45) it was .27 (.21-.34) for ICD-10. These values show improvement of ICD-11 over 
ICD-10, which is encouraging given low diagnostic agreement for Schizoaffective Disorder. For 
comparison, the kappas for Schizophrenia, Depressive Episode with Psychotic Symptoms, and 
Manic Episode with Psychotic Symptoms were .42 (.34-.49), .61 (.53-.68), and .87 (.83-.92), 
respectively, for ICD-11; for ICD-10 they were .34 (.26-.41), .66 (.60-.72), and .91 (.88-.95). 
3.2 Comparison 1 – Schizophrenia vs. Schizoaffective Disorder 
 Participants differentiated Schizophrenia from Schizoaffective Disorder regardless of 
which diagnostic system they used, ICD-11 χ2(2) = 66.35, p < .001; ICD-10 χ2(2) = 43.94, p < 
.001. Despite the distinction, participants evidenced low diagnostic accuracy for Vignette 2. For 
ICD-11, they diagnosed the first vignette relatively well as Schizophrenia (72.14% correct), but 
struggled to diagnose the second vignette as Schizoaffective Disorder (only 44.29% correct). 
However, participants using the ICD-10 performed significantly worse at the distinction relative 
to ICD-11, G2(4) = 11.50, p < .05. The difference in performance was not attributable to Vignette 
1, χ2(2) = 2.11, ns, but rather from differences on Vignette 2, χ2(2) = 9.36, p < .01. Diagnoses for 
Comparison 1 can be found in Table 2.  
3.3 Comparison 2 – Schizoaffective Disorder vs. Depressive Episode with Psychotic 
Symptoms 
 
 For the second comparison, participants using both diagnostic systems differentiated 
Schizoaffective Disorder from a Depressive Episode with Psychotic Symptoms, ICD-11 χ2(2) = 
141.79, p < .001; ICD-10 χ2(2) = 206.64, p < .001. As with Comparison 1, clinicians struggled 
with the diagnosis of Vignette 2. However, in this comparison the two systems were not 
statistically different in the diagnosis of Vignette 2 (χ2(2) = 3.28, ns), Vignette 3A (χ2(2) = 5.19, 
ns), or overall (G2(4) = 8.78, ns). Diagnoses for Comparison 2 can be found in Table 3. 
3.4 Comparison 3 – Schizoaffective Disorder vs. Manic Episode with Psychotic Symptoms 
 
 Participants differentiated Schizoaffective Disorder from a Manic Episode with Psychotic 
Symptoms on both diagnostic systems, ICD-11 χ2(2) = 210.25, p < .001; ICD-10 χ2(2) = 224.01, 
p < .001. Vignette 2 included depressive symptoms in the presentation of Schizoaffective 
Disorder, so the differentiation of vignettes may be based mostly on clinicians’ recognition of the 
difference between depressive and manic features. That said, participants using ICD-11 were 
slightly more accurate diagnosing Vignette 2 than those using ICD-10, χ2(2) = 6.31, p < .05. 
There was no difference between systems on Vignette 3B, χ2(2) = 3.47, ns. Diagnoses for 
Comparison 3 can be found in Table 4. 
3.5 Symptom Endorsement for Misdiagnoses 
 We also examined participants’ endorsement of the diagnostic requirements when they 
gave an incorrect diagnosis for Vignette 2. We combined the follow-up diagnostic questions for 
the three comparisons in an effort to determine why clinicians provided an incorrect diagnosis. 
The most common misdiagnosis across comparisons was diagnosing Schizophrenia when 
Schizoaffective Disorder was the correct diagnosis.  Across all three comparisons, 131 (31.95%) 
of the 410 participants using ICD-11 misdiagnosed Vignette 2 with Schizophrenia. Overall, there 
was high agreement on the requirement that at least two symptoms of Schizophrenia were 
present (n = 127, 96.95%), at least one symptom was a core symptom (n = 130, 99.24%), 
symptoms were present for at least one month (n = 126, 96.18%), and medical causes and 
substance use were ruled out (n = 117, 89.31%; n = 115, 87.79%).  However, discrepancies 
appeared to be related to the presence of sufficient mood symptoms that would warrant another 
diagnosis.  Eighteen (13.74%) participants agreed that there were sufficient mood symptoms to 
warrant another diagnosis (but gave a diagnosis of Schizophrenia anyway), and 95 (72.52%) 
denied the presence of sufficient mood symptoms.   
 A slightly higher proportion of participants using ICD-10 misdiagnosed Vignette 2 as 
Schizophrenia (194 of 463; 41.90%). Of these, participants agreed on the presence of psychotic 
symptoms (n = 191, 98.45%), their duration being greater than a month (n = 188, 96.91%), and 
that the symptoms were not due to another medical condition (n = 185, 95.36%) or substance use 
(n = 182, 93.81%). However, there were discrepancies about the presence of mood symptoms, 
with 84 (43.30%) participants indicating that there were mood symptoms present, 90 (46.39%) 
denying the presence of mood symptoms, and 18 (9.28%) expressing uncertainty.   
 Although to a lesser degree than Schizophrenia, Vignette 2 was also misdiagnosed as a 
Depressive Episode with Psychotic Symptoms (n = 72, 17.56%) using ICD-11. There was 
general consensus on the presence of a sufficient number of depressive symptoms (n = 69, 
95.83%), symptom duration (n= 70, 97.22%), symptoms from the affective cluster (i.e., 
depressed mood or loss of interest/pleasure, n = 72, 100%), presence of hallucinations or 
delusions (n = 72, 100%), functional impairment (n = 70, 97.22%), and medical causes and 
substance use ruled out (n= 59, 81.94%; n = 65, 90.28%). There appeared to be the most 
discrepancies related to whether the psychotic symptoms occurred outside of the mood episode 
with 52 (72.22%) participants endorsing that psychotic symptoms did not occur outside of the 
mood episode, 14 (19.44%) stating they were unsure, and 6 (8.33%) correctly endorsing that they 
did.  
 A misdiagnosis of a Depressive Episode with Psychotic Symptoms for participants using 
ICD-10 was comparable to those using ICD-11 (n = 78). However, there was less consensus on 
the presence of the required symptoms. Participants generally agreed that the core symptoms of a 
severe depressive episode were present (n = 61, 78.21%), along with additional depressive 
symptoms (n = 59, 75.64%), for the required duration (n = 66, 84.6%), that significantly 
impacted the person’s functioning (n = 59, 75.64%), along with hallucinations or delusions (n = 
69, 88.46%), not caused by another medical problem (n = 61, 78.21%) or substance use (n = 65, 
83.33%). Once again, there was substantial disagreement about whether the symptoms met the 
requirements for a psychotic disorder, with 22 (28.21%) participants saying yes, 24 (30.77%) 
saying no, and 24 (30.77%) expressing uncertainty. 
4. Discussion 
The purpose of the current study was to examine clinicians’ ability to apply the proposed 
ICD-11 diagnostic guidelines for Schizoaffective Disorder to case vignettes. To accomplish this 
goal, we compared the current ICD-10 guidelines to the proposed ICD-11 guidelines to 
determine if the new guidelines could be applied with at least similar accuracy. Many of the 
proposed changes in the guidelines aimed to increase clinical utility by removing potentially 
confusing or overlapping diagnoses and providing more information for each diagnosis (Gaebel 
et al., 2012). Based on the results from this first phase of the field trials, clinicians applied the 
ICD-11 guidelines more accurately than the ICD-10 guidelines; however, the improvements 
were modest. ICD-11 guidelines include information related to differential diagnosis and 
additional features of the disorders. This additional information is not explicitly stated in ICD-10 
and therefore could have contributed to ICD-11’s improvements over ICD-10.  
Although weak, diagnostic agreement for Schizoaffective Disorder in ICD-11 showed 
improvement over ICD-10. It is important to note that the kappas obtained in this study are not 
directly comparable to typical studies of diagnostic reliability, like the meta-analysis described in 
the introduction (Santelmann et al., 2015). Because of the differences in methodology (i.e., 
vignettes versus live patients), the reader should interpret the kappas from this study only in 
relative terms (i.e., improvement from ICD-10 to ICD-11 within this study). When examining 
the follow-up diagnostic questions, the most common discrepancy appeared to be related to the 
presence of mood symptoms in patients with clear symptoms of Schizophrenia. The vignettes 
were not likely the cause of the confusion because all of the vignettes were pretested and found 
to meet the correct diagnostic guidelines. Instead, the misdiagnoses and the corresponding 
responses to diagnostic questions could be the result of clinicians missing relevant information 
from the vignettes, falling prey to confirmatory biases, or actual confusion about the diagnostic 
guidelines. 
 Regarding the first explanation, it is possible that clinicians did not properly attend to the 
information in the vignette. However, lack of attention to details would not have resulted in the 
pattern of responses we observed, as they were selectively careless with one vignette and not 
others. More likely is the notion that the information about mood symptoms in Vignette 2 was 
overshadowed by the more salient psychotic symptoms. Diagnostic overshadowing has been 
shown to occur in a variety of areas (Alford and Locke, 1984; Reiss et al., 1982; Wood and 
Tracey, 2009), including with mood and psychotic symptoms overshadowing substance abuse 
problems (Goethe and Ahmadi, 1991; Skodol et al., 1984). However, we are not aware of any 
studies to date that explicitly examine psychotic symptoms overshadowing mood symptoms, as 
might have occurred in this study. 
 Second, the misdiagnoses could be due to clinicians’ confirmatory biases. In other words, 
they may have started to formulate a diagnostic conclusion (e.g., Schizophrenia), which led them 
to discount or ignore other relevant symptoms (Garb, 1998). For example, in a sample of 
psychiatrists and medical students, 13% and 25% (respectively) engaged in confirmatory biases 
when searching for diagnostic information, leading to substantially increased chances of an 
incorrect diagnosis (Mendel et al., 2011). 
 Third, the confusion could be due to the guidelines themselves. Because the proposed 
revisions for the ICD are intended to increase the clinical utility of the diagnostic system, it will 
be important moving forward to identify ways that may aid clinicians’ ability to accurately 
differentiate Schizoaffective Disorder from other psychotic and mood disorders. Although there 
is inherently going to be some level of overlap amongst specific psychotic and mood disorders 
due to the dimensional nature of the symptoms (Jonathan et al., 2013; Kendell and Jablensky, 
2003; Malhi et al., 2008), it is still of the upmost importance to ensure that clinicians are able to 
meaningfully and reliably differentiate these diagnoses. ICD-11 has attempted to better 
differentiate Schizoaffective Disorder from Schizophrenia and mood disorders by providing 
more explicitly stated guidelines and differential diagnostic information.  However, based on the 
present study, that additional information likely will not prove to be enough to substantially 
increase the diagnostic reliability of Schizoaffective Disorder. Lack of familiarity with the new 
guidelines may have contributed to the results, and clinicians may require additional education 
about the difference to help increase diagnostic reliability. 
 Last, the concept of Schizoaffective Disorder itself may be problematic. It exists as a 
practical solution to diagnosing individuals with overlapping psychotic and affective symptoms. 
Some solution is necessary, which is why the Working Group did not consider deleting 
Schizoaffective Disorder at this time. However, other solutions (like providing dimensional 
ratings) may capture the symptom picture more reliably than a categorical diagnosis. The 
inclusion in ICD-11 of separate dimensional ratings for depressive and manic mood symptoms in 
psychotic disorders would appear to be a step that direction (Keeley & Gaebel, 2018). 
Nonetheless, the development of future classification systems may wish to revisit the 
conceptualization of Schizoaffective Disorder as a means of capturing combined mood and 
psychotic symptom presentations, possibly by implementing a fully dimensional scheme of 
psychotic and mood diagnoses if ratings prove to be clinically useful. Simply continuing to make 
iterative refinements in categorical guidelines for Schizoaffective Disorder is unlikely to produce 
substantial gains. 
4.1 Limitations 
By having such a large and diverse sample of participants, we would hope our findings 
would generalize to ICD-11 users in clinical practice. However, the majority of respondents were 
psychiatrists, which is not representative of mental health professionals generally (International 
Advisory Group, 2011). In higher-income countries, the proportion of psychiatrists to the general 
population is relatively high, but this distribution is not seen is lower-income countries which 
also utilize the ICD as their main diagnostic system (WHO, 2005).     
Another limitation of this study that must be considered is the use of vignettes as opposed 
to live clinical cases. Vignettes were used to control for some of the inevitable variation in 
symptom presentations that would be present in a clinical population (Evans et al., 2015). 
However, in controlling for these variations, we limit our current findings to clear case 
presentations. Vignettes also limit the amount of information presented to participants, which 
would not likely be a problem found in a clinical setting. Specifically, the limited amount of 
information may alter a clinician’s diagnosis or diagnostic considerations. Presenting only the 
prominent symptoms that would apply to a diagnosis may make diagnosing the vignette easier as 
compared to having an abundance of information that must be analyzed for accurate differential 
diagnoses in a clinical setting. A further limitation is that we only presented respondents with the 
diagnostic guidelines for psychotic disorders and select mood and stress disorders. Although we 
gave the clinicians in this study the option to write-in another diagnosis that was not listed, we 
did not include any of the diagnostic information for other potential diagnoses. Having these 
additional guidelines available may have increased the difficultly for clinicians to choose the 
accurate diagnosis because they would have had more options available. These limitations were 
addressed with additional clinic-based field trials in which clinicians interviewed patients to 
provide a diagnosis; kappas for Schizophrenia (0.87, 95%CI 0.84-0.89) and Schizoaffective 
Disorder (0.66, 95%CI 0.58-0.72) were higher for clinician interviews than in this study (Reed et 
al., 2018). This somewhat counterintuitive difference might be due to a clinicians’ ability to ask 
clarifying questions in a live interview, which is not an option in a fixed vignette.      
The final major limitation of this study is that we did not explicitly ask why clinicians 
were picking one diagnosis (correct or incorrect) over another diagnosis. For some of the 
comparisons being made, this differential diagnosis information could have been particularly 
helpful in determining which aspects of the diagnostic guidelines were aiding in a correct 
diagnosis or possibly negatively impacting respondents’ ability to choose the correct diagnosis. 
Further analyses of the participants’ responses could perhaps aid in generating ideas for why 
certain misdiagnoses were made while others were not. 
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Table 1. Participant demographics by language 
 
 Chinese 
n = 100 
English 
n = 364 
French 
n = 78 
Japanese 
n = 118 
Russian 
n = 108 
Spanish 
n = 105 
 f (%) f (%) f (%) f (%) f (%) f (%) 
Region       
     Africa 0 13 (3.6) 6 (7.7) 0 0 0 
     North America 0 90 (24.7) 4 (5.1) 0 0 1 (1.0) 
     South America 0 22 (6.0) 1 (1.3) 0 0 74 (70.5) 
     Eastern Mediterranean 0 20 (5.5) 8 (10.3) 0 0 0 
     Europe 0 156 (42.9) 59 (75.6) 0 106 (98.1) 30 (28.6) 
     South Eastern Asia 0 42 (11.5) 0 0 0 0 
     Asian Western Pacific 100 (100) 0 0 117 (99.2) 0 0 
     Oceania Western Pacific 0 20 (5.5) 0 0 0 0 
     Other 0 1 (0.3) 0 1 (0.8) 2 (1.9) 0 
       
Gender       
     Male 63 (63.0) 176 (48.4) 46 (59.0) 93 (78.8) 65 (60.2) 58 (55.2) 
     Female 37 (37.0) 188 (51.6) 32 (41.0) 25 (21.2) 43 (39.8) 46 (43.8) 
       
Profession       
     Counseling 4 (4.0) 26 (7.1) 0 3 (2.5) 1 (0.9) 0 
     Psychiatry 90 (90.0) 156 (42.9) 54 (69.2) 96 (81.4) 95 (88.0) 40 (38.1) 
     Nursing 0 11 (3.0) 2 (2.6) 1 (0.8) 0 1 (1.0) 
     Psychology 4 (4.0) 134 (36.8) 22 (28.2) 14 (11.9) 10 (9.3) 51 (48.6) 
     Social work 2 (2.0) 5 (1.4) 0 2 (1.7) 0 2 (1.9) 
     Other 0 32 (8.8) 0 2 (1.7) 2 (1.9) 11 (10.2) 
       
 M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) 
Age 40.63 
(9.50) 
45.61 
(11.15) 
46.01 
(12.12) 
45.99 
(11.01) 
42.90 
(11.90) 
47.41 
(11.85) 
       
Years of Experience 12.11 
(8.91) 
14.29 
(9.94) 
16.42 
(10.69) 
14.65 
(10.12) 
17.10 
(11.25) 
18.62 
(10.93) 
       
 
  
Table 2. Comparison 1 diagnoses: Schizophrenia vs. Schizoaffective Disorder  
 
 ICD-11 ICD-10 
 Vignette 1 Vignette 2 Vignette 1 Vignette 2 
Schizophrenia 101  
(72.14%) 
37 
(26.43%) 
116 
(71.60%) 
64 
(39.51%) 
Schizoaffective Disorder  12 
(8.57%) 
62 
(44.29%) 
8 
(4.94%) 
46 
(28.40%) 
Depressive Episode with Psychotic 
Symptoms 
10 
(7.14%) 
32 
(22.86%) 
12 
(7.41%) 
35 
(21.60%) 
Another Diagnosis 17 
(12.14%) 
9 
(6.43%) 
26 
(16.05%) 
17 
(10.49%) 
Note: bold denotes the correct option; n = 140 for ICD-11 and 162 for ICD-10. 
  
  
Table 3. Comparison 2 diagnoses: Schizoaffective Disorder vs. Depressive Episode with 
Psychotic Symptoms 
 
 ICD-11 ICD-10 
 Vignette 2 Vignette 3A Vignette 2 Vignette 3A 
Schizophrenia 47 
(39.17%) 
0 
(0%) 
73 
(47.10%) 
0 
(0%) 
Schizoaffective Disorder  51 
(42.50%) 
6 
(5.00%) 
50 
(32.26%) 
1 
(0.65%) 
Depressive Episode with Psychotic 
Symptoms 
11 
(9.17%) 
103 
(85.83%) 
14 
(9.03%) 
140 
(90.32%) 
Another Diagnosis 11 
(9.17%) 
11 
(9.17%) 
18 
(11.61%) 
14 
(9.03%) 
Note: bold denotes the correct option; n = 120 for ICD-11 and 155 for ICD-10. 
 
  
Table 4. Comparison 3 diagnoses: Schizoaffective Disorder vs. Manic Episode with Psychotic 
Symptoms 
 
 ICD-11 ICD-10 
 Vignette 2 Vignette 
3B 
Vignette 2 Vignette 
3B 
Schizophrenia 47 
(31.33%) 
2 
(1.33%) 
57 
(39.04%) 
2 
(1.37%) 
Schizoaffective Disorder  66 
(44.00%) 
4 
(2.67%) 
45 
(30.82%) 
5 
(3.42%) 
Manic Episode with Psychotic 
Symptoms 
0 
(0%) 
122 
(81.33%) 
1 
(0.68%) 
128 
(87.67%) 
Depressive Episode with Psychotic 
Symptoms 
29 
(19.33%) 
0 
(0%) 
29 
(19.86%) 
0 
(0%) 
Another Diagnosis 8 
(5.33%) 
22 
(14.67%) 
14 
(9.59%) 
11 
(7.553%) 
Note: bold denotes the correct option; n = 150 for ICD-11 and 146 for ICD-10. 
 
 
